NCT02352623已完成不适用
Quality of Life and Surgical Late Effects of Melanoma Treatment
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 435
- 试验地点
- 1
- 主要终点
- Global Health Score
研究概览
简要总结
Health-related Quality of life in Danish stage IB-III cutaneous melanoma patients.
详细描述
The aim of the PhD-study is to evaluate, in a large cohort of Danish melanoma patients:
- Health-related quality of life assessing psychological, physical and social well-being
- Physical long term side effects (lymphoedema, scarring and neuropathic pain)
- Lymphoedema assessed by clinical examination and DXA scans
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •AJCC stage IB-III cutaneous melanoma patients
- •At least one year follow-up after melanoma surgery
排除标准
- •Pregnancy
- •Bilateral axilla or groin melanoma surgery
结局指标
主要结局
Global Health Score
时间窗: 12 months
Quality of life will be assessed with the questionnaire EORTC QLQ-C30 v.3.0
次要结局
- Lymphoedema(12 months)
- Volume and tissue composition assessed with DXA scan(12 months)
- Depression(12 months)
- Anxiety(12 months)
- Neuropathic pain(12 months)
研究者
caroline gjørup
M.D. ph.d. student
Herlev Hospital
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Quality of life research among melanoma patients that have been treated with immunotherapy, or targeted therapy and/or surgeryKwaliteit van LevenQuality of Life10040900NL-OMON55207Antoni van Leeuwenhoek Ziekenhuis700
尚未招募
不适用
Melanoma patients and Quality of Life after active treatmentMelanoma (stage III/IV)NL-OMON26948o sponsors, the study is investigator initiated500
已完成
不适用
Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint InhibitorsMetastatic MelanomaNCT03326973Memorial Sloan Kettering Cancer Center107
已完成
不适用
Quality of Life in Patients With Multimetastatic Melanoma Currently in Remission (QUALM)Melanoma (Skin) Stage IVRemissionNCT03518814Lille Catholic University40
招募中
不适用
Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.Kidney CancerHead Neck CancerBreast CancerGastric CancerMelanomaBladder CancerLung CancerSkin CancerNCT05878964Fondazione Policlinico Universitario Agostino Gemelli IRCCS420